Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

543 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-dose cyclosporine with mycophenolate mofetil induces similar calcineurin activity and cytokine inhibition as does standard-dose cyclosporine in stable renal allografts.
Grinyó JM, Cruzado JM, Millán O, Caldés A, Sabaté I, Gil-Vernet S, Serón D, Brunet M, Campistol JM, Torras J, Martorell J. Grinyó JM, et al. Among authors: campistol jm. Transplantation. 2004 Nov 15;78(9):1400-3. doi: 10.1097/01.tp.0000141227.63639.63. Transplantation. 2004. PMID: 15548982
Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.
Ruiz JC, Campistol JM, Grinyó JM, Mota A, Prats D, Gutiérrez JA, Henriques AC, Pinto JR, García J, Morales JM, Gómez JM, Arias M. Ruiz JC, et al. Among authors: campistol jm. Transplantation. 2004 Nov 15;78(9):1312-8. doi: 10.1097/01.tp.0000137322.65953.0a. Transplantation. 2004. PMID: 15548969 Free article. Clinical Trial.
Improved renal function, with similar proteinuria, after two years of early tacrolimus withdrawal from a regimen of sirolimus plus tacrolimus.
Morales JM, Grinyó JM, Campistol JM, García-Martínez J, Arias M, Paul J, Sánchez-Fructuoso A, Brunet M, Granados E, Munoz-Robles JA. Morales JM, et al. Among authors: campistol jm. Transplantation. 2008 Aug 27;86(4):620-2. doi: 10.1097/TP.0b013e3181821c25. Transplantation. 2008. PMID: 18724234 Clinical Trial.
Early-onset anemia after kidney transplantation is an independent factor for graft loss: a multicenter, observational cohort study.
Pascual J, Jiménez C, Franco A, Gil M, Obrador-Mulet AR, Gentil MA, Romero R, Grinyó JM, Hernández D, Morales JM, Pallardó LM, Serón D, Arias M, Campistol JM; ANEMIART Study Group. Pascual J, et al. Among authors: campistol jm. Transplantation. 2013 Oct 27;96(8):717-25. doi: 10.1097/TP.0b013e31829f162e. Transplantation. 2013. PMID: 23896555
Use of De Novo mTOR Inhibitors in Hypersensitized Kidney Transplant Recipients: Experience From Clinical Practice.
Cucchiari D, Molina-Andujar A, Montagud-Marrahi E, Revuelta I, Rovira J, Ventura-Aguiar P, Piñeiro GJ, De Sousa-Amorim E, Esforzado N, Cofán F, Torregrosa JV, Ugalde-Altamirano J, Ricart MJ, Centellas-Pérez FJ, Solè M, Martorell J, Ríos J, Campistol JM, Diekmann F, Oppenheimer F. Cucchiari D, et al. Among authors: campistol jm. Transplantation. 2020 Aug;104(8):1686-1694. doi: 10.1097/TP.0000000000003021. Transplantation. 2020. PMID: 32732848
543 results